CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.Analytical data for Cumyl-Cb-MeGaClone. Hungarian Institute for Forensic Science, 9 April 2020
See also 5F-CUMYL-PEGACLONE CUMYL-5F-P7AICA CUMYL-CH-MEGACLONE CUMYL-BC-HPMEGACLONE-221 CUMYL-CBMINACA CUMYL-THPINACA
References